✦ LIBER ✦

Pharmacokinetic and Pharmacodynamic Aspects of Oral Moxifloxacin 400 mg/day in Elderly Patients with Acute Exacerbation of Chronic Bronchitis

✍ Scribed by Dr Federico Pea, Federica Pavan, Emilio Lugatti, Flavio Dolcet, Giovanni Talmassons, Maria Consuelo Screm, Mario Furlanut

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy and Tolerability of Moxifloxaci

✍ J. Barth, Prof. H. Landen 📂 Article 📅 2003 🏛 Springer International Publishing AG 🌐 English ⚖ 123 KB

Bronchopulmonary pharmacokinetic and pha

✍ David P. Nicolau; Christina Sutherland; Donna Winget; Robert P. Baughman 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 196 KB

Pharmacokinetic/pharmacodynamic predicto

✍ Barbara Meinl; Judith M Hyatt; Alan Forrest; Sanford Chodosh; Jerome J Schentag 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 108 KB

A randomized, double-blind study compari

✍ S Sethi; C Fogarty; A Fulambarker 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 222 KB

The safety and efficacy of short course

✍ C.A. DEABATE; C.P. MATHEW; J.H. WARNER; A. HEYD; D. CHURCH 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 198 KB

Randomized, double-blind study comparing

✍ R.G. Masterton; C.J. Burley 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 102 KB